We therefore suggested that gene knockdown of KLF4 via intratracheal administration of AAV1‐KLF4‐shRNA would provide selective gene silencing to the pulmonary circulation to prevent or ameliorate pulmonary vascular remodelling and right ventricular hemodynamic consequences in CS‐PH. This evidence concerns the gene KLF4 and Cowden syndrome 1.